The Market for Pediatric Drugs In India Is Expected to cross INR 960 Billion in the Future: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit India pediatric drugs and vaccine market has witnessed tremendous growth in the last five years largely due to high number of annual births recorded at around 25 million, launch of generic formulations of several pediatric drugs including flavored TB drugs, inclusion of several vaccines in the national immunization schedule of the country and inclining coverage of children vaccination under national immunization schedule. In the last few years, medium to large Indian pharmaceutical companies have aggressively invested in international acquisition of companies to strengthen their foothold in developed and emerging markets globally. India’s healthcare spending is one of the lowest in the world with the country spending only 1.2% of its GDP on health care as compared to 8.3% by the US and global mean of 5.4%, as of FY’2016. It also has the highest infant mortality rate and maternal mortality rate in the world. This has propelled the pharmaceutical industry to address the existing unmet challenges. The industry has come out with drug formulations for infants against some life threatening diseases such as tuberculosis and pneumonia which has helped to curb down the infant mortality rate in the country. The market for pediatric drugs and vaccines in India is almost entirely driven by companies manufacturing generic drugs. Almost all pharmaceutical companies operating in the country have expertise in developing generic drugs formulations of branded drugs developed by international companies so as to cater with underprivileged populations at a much cheaper price. India has a huge disease burden and a large part of drugs sold in the country is meant for the treatment of several infectious and non-infectious diseases prevalent in the pediatric population. Pediatric drug are commonly used for diarrheal diseases such as cholera and viral gastroenteritis. Respiratory diseases including pneumonia and tuberculosis are other commonly treatable conditions for which drugs find extensive usage in the country. Anti-infectives were the most frequently prescribed drug class by pediatricians, with over 80% of the prescriptions had some form of prescribed antibiotics. This is due to the wide scale prevalence of children being affected by respiratory diseases or some sort of microbial infections at regular basis. India has emerged as leading vaccine producer in the world, in terms of doses of vaccines produced, and has about 12 major vaccine manufacturing facilities across the country. Vaccines manufactured in these facilities are offered in both national and international market (over 150 countries). With over 25 million births every year, the domestic market for vaccines in India is huge. The country has been self sufficient in meeting the domestic needs, with private sector responsible for providing a large part of the supply needs. Key Factors Considered in the Report Pediatric Drug Development Trends Pediatric Vaccine Market Number Of Pediatrician Statistics Pediatric Tuberculosis Drug Market Drug Information, Dosage, Side Effects Vaccines Market Growth India Drug Pipeline Pediatric Drug Vaccine Clinical Trials India Pediatric Drug Market Industry Size New Drug Launches India Pharma Sector Pediatric Vaccine Serum Institute Of India For more information on the market research report please refer to the below link: https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Attenuated vaccines Industry Developments, Conjugate Vaccines Contribution India, Dosage, Drug Information, Drug Pipeline Pediatric Drug, Future Growth India Pediatric Vaccine, Generic Pediatric Drugs Sales, India Anti-infectives Market Growth, India Inactivated Vaccines Industry Size, India Pediatric Drugs Market, Indian Pediatrics Market, Kids Antihistamines Market Sales, Lupin Pediatric Drug Revenue, Market Share Sun Pharmaceuticals Pediatric Drug, New Drug Launches India Pharma Sector, Number of Pediatrician Statistics, Pediatric Drug Development, Pediatric Drug Market Industry Size, Pediatric Drugs Revenue Pharma Sector, Pediatric tuberculosis drug Market, Pediatric Vaccine Serum Institute of India, Recombinant Vaccines Market Competition, Revenue Cardiovascular Drugs India, Side Effects, Subunit Vaccines Sales India, Toxoid Vaccines Market share, Trends Pediatric Vaccine Market, Vaccine Clinical Trials India, Vaccines Market Growth India
